Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 7, Status: Authorised

New product information wording: extracts from PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC

Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 18, Status: Authorised